Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1

Oncogene

Volumn 23, Issue 22, 2004, Pages 4023-4031

  Pinte, Sébastien ^a   Guérardel, Cateline ^a,c   Deltour Balerdi, Sophie ^a,d   Godwin, Andrew K ^b   Leprince, Dominique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b FOX CHASE CANCER CENTER   (United States)

^c ACADEMIA SINICA   (Taiwan)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

17p13.3; 5 UTR; BTB POZ; CpG island; HIC1; MDS; Promoter

Indexed keywords

GENE PRODUCT; HYPERMETHYLATED IN CANCER 1 PROTEIN; PROTEIN C; PROTEIN G; TATA BINDING PROTEIN; UNCLASSIFIED DRUG; HIC1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CELL LINE; CHROMOSOME 17P; DONOR SITE; EXON; GENE DELETION; GENE IDENTIFICATION; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MILLER DIEKER SYNDROME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TUMOR SUPPRESSOR GENE; ANIMAL; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; OVARY; RABBIT;

ACRONICTA LEPORINA; ANIMALIA; MURINAE; STAPHYLOCOCCUS PHAGE 3A;

ANIMALS; BASE SEQUENCE; CONSERVED SEQUENCE; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OVARY; PROMOTER REGIONS (GENETICS); RABBITS; RATS; TRANSCRIPTION FACTORS;

EID: 2542580146     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207504     Document Type: Article

References (22)

1. Baylin SB, Esteller M Rountree MR, Bachman KE, Schuebel K and Hermann JG. (2001). Hum. Mol. Genet., 10, 687-692.
2. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP. (1998). Adv. Cancer Res., 72, 141-196.
3. Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A and Godwin AK. (1999). Cancer Res., 59, 4973-4983.
4. Carter MG, Johns MA, Zeng X, Zhou L, Zink MC, Mankowski JL, Donovan DM and Baylin SB. (2000). Hum. Mol. Genet., 9, 413-419.
5. Chen WY, Zeng X, Carter M, Morell CN, Chiu Yen R-W, Esteller M, Watkins DN, Herman JG, Mankowski JL and Baylin SB. (2003). Nat. Genet., 33, 197-202.
6. Deltour S, Guérardel C and Leprince D. (1999). Proc. Natl. Acad. Sci. USA, 96, 14831-14836.
7. Feltus FA, Lee EK, Costello JF, Plass C and Vertino PM. (2003). Proc. Natl. Acad. Sci. USA, 100, 12253-12258.
8. Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB and Gabrielson E. (1998). Oncogene, 16, 2159-2164.
9. Guérardel C, Deltour S, Pinte S, Monte D, Bègue A, Godwin AK and Leprince D. (2001). J. Biol. Chem., 276, 3078-3089.
10. Grimm C, Spörle R, Schmid TE, Adler I-D, Adamski A, Schughart K and Graw J. (1999). Hum. Mol. Genet., 8, 697-710.
11. Han B, Dong Z, Liu Y, Chen Q, Hashimoto K and Zhang J-T. (2003). Oncogene, 22, 5325-5337.
12. Kanai Y, Hui A, Sun L, Ushijima S, Sakamoto M, Tsuda M and Hirohashi S. (1999). Hepatology, 29, 703-709.
13. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
14. Kozak M. (1991). J. Cell Biol., 115, 887-903.
15. Liscia DS, Morizio R, Venesio T, Palenzona C, Donadio M and Callahan R. (1999). Br. J. Cancer, 80, 821-826.
16. Makos-Wales M, Biel M, El Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ and Baylin SB. (1995). Nat. Med., 1, 570-577.
17. Melki JR, Vincent PC and Clark SJ. (1999). Leukemia, 13, 877-883.
18. Philips NJ, Ziegler MR and Deaven LL. (1996). Cancer Lett., 102, 85-90.
19. Rood BR, Zhang H, Weitman DM and Cogen PH. (2002). Cancer Res., 62, 3794-3797.
20. Schultz D, Vanderveer L, Berman DB, Hamilton TC, Wong AJ and Godwin AK. (1996). Cancer Res., 56, 1997-2002.
21. Yingling J, Toyo-oka K and Wynshaw-Boris A. (2003). Am. J. Hum. Genet., 73, 475-488.
22. Yuasa Y. (2002). Mech. Ageing Dev., 123, 1649-1654.